Rae S M Yeung Selected Research

Rheumatoid Factor

1/2022	A Comparison of International League of Associations for Rheumatology and Pediatric Rheumatology International Trials Organization Classification Systems for Juvenile Idiopathic Arthritis Among Children in a Canadian Arthritis Cohort.
1/2021	Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic Arthritis.
11/2019	Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.
1/2019	Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization.
1/2018	Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis.
1/2018	Health-Related Quality of Life in an Inception Cohort of Children With Juvenile Idiopathic Arthritis: A Longitudinal Analysis.
1/2016	The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
12/2014	Description of active joint count trajectories in juvenile idiopathic arthritis.
4/2010	Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort.
8/2009	Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rae S M Yeung Research Topics

Disease

18	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2020 - 04/2002
16	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2022 - 08/2009
13	Aneurysm (Aneurysms) 06/2017 - 04/2002
12	Arthritis (Polyarthritis) 01/2021 - 06/2006
10	Fever (Fevers) 06/2017 - 04/2002
9	Vasculitis (Vasculitides) 05/2022 - 09/2004
9	Inflammation (Inflammations) 01/2021 - 05/2004
5	Microscopic Polyangiitis 05/2022 - 01/2017
5	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 05/2022 - 01/2017
4	Infections 04/2022 - 09/2004
4	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2018
4	Psoriatic Arthritis 01/2021 - 08/2009
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2022 - 01/2017
2	Renal Insufficiency (Renal Failure) 05/2022 - 01/2021
2	Takayasu Arteritis (Arteritis, Takayasu's) 06/2019 - 11/2017
2	Glomerulonephritis 12/2017 - 01/2017
2	Arteritis 03/2011 - 05/2006
1	Spondylitis 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Critical Illness (Critically Ill) 03/2020
1	Chronic Disease (Chronic Diseases) 03/2020
1	Dermatomyositis (Dermatopolymyositis) 03/2020
1	Polymyositis 03/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2020
1	Hemolytic Anemia 01/2020
1	Hemolysis 01/2020
1	Uveitis 11/2019
1	Systemic Vasculitis 06/2019
1	Rheumatic Diseases (Rheumatism) 03/2018
1	Neoplasms (Cancer) 03/2018
1	Rheumatoid Arthritis 01/2018
1	Disease Susceptibility (Diathesis) 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2017
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2017
1	Hemorrhage 10/2016
1	Vascular Remodeling 01/2014
1	Necrosis 05/2012
1	Marfan Syndrome (Marfan's Syndrome) 03/2011
1	Hyperferritinemia 10/2010
1	Pain (Aches) 08/2009

Drug/Important Bio-Agent (IBA)

15	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 04/2002
10	Rheumatoid FactorIBA 01/2022 - 08/2009
7	Biological ProductsIBA 05/2021 - 12/2014
7	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2017 - 04/2002
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2017
3	Rituximab (Mabthera)FDA Link 04/2022 - 03/2020
3	Antinuclear AntibodiesIBA 01/2022 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
3	sulfated polyvinyl alcoholIBA 06/2019 - 09/2016
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2017 - 12/2005
3	Hemoglobins (Hemoglobin)IBA 06/2017 - 12/2009
3	ElastinIBA 03/2011 - 05/2006
2	Antirheumatic Agents (DMARD)IBA 04/2022 - 01/2016
2	Immunoglobulin G (IgG)IBA 04/2022 - 01/2020
2	Serum AlbuminIBA 01/2021 - 04/2002
2	CytokinesIBA 03/2020 - 05/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2018 - 05/2006
2	AlbuminsIBA 01/2012 - 12/2009
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2011 - 03/2008
1	GlucocorticoidsIBA 05/2022
1	Immunoglobulins (Immunoglobulin)IBA 04/2022
1	Immunoglobulin M (IgM)IBA 04/2022
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2021
1	ChemokinesIBA 03/2020
1	Blood Group Antigens (Blood Groups)IBA 01/2020
1	ABO Blood-Group SystemIBA 01/2020
1	AntibodiesIBA 01/2020
1	Adenosine DeaminaseIBA 10/2019
1	AutoantibodiesIBA 06/2019
1	Infliximab (Remicade)FDA Link 03/2018
1	AllergensIBA 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2018
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 09/2017
1	SteroidsIBA 09/2017
1	Proteins (Proteins, Gene)FDA Link 12/2016
1	C-Reactive ProteinIBA 12/2016
1	triphosphoric acid (triphosphate)IBA 11/2016
1	InflammasomesIBA 11/2016
1	Inositol (Myoinositol)IBA 11/2016
1	Oxygen (Dioxygen)IBA 10/2016
1	Prostaglandins AIBA 01/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2015
1	Atorvastatin (Lipitor)FDA Link 01/2014
1	Oxidoreductases (Dehydrogenase)IBA 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2012
1	Fibrinolysin FDA Link 03/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2011
1	EnzymesIBA 10/2010
1	Phosphotransferases (Kinase)IBA 09/2010

Therapy/Procedure

10	Therapeutics 03/2018 - 04/2002
3	Biological Therapy 01/2022 - 09/2012
3	Critical Care (Surgical Intensive Care) 01/2022 - 11/2020
1	Plasmapheresis 05/2022
1	Remission Induction 05/2022
1	Kidney Transplantation 12/2017
1	Treatment Delay 06/2017
1	Length of Stay 05/2010
1	Retreatment 05/2010
1	Aftercare (After-Treatment) 05/2010